Zentiva and Lupin Sign License and Supply Agreement for TNF alpha inhibitor biosimilar medicine

PRAGUE, July 9, 2025 /PRNewswire/ -- Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for commercialization of...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsBiosimilar

FlexXray Expands Global Footprint with European Acquisition and North American Growth Strategy

FlexXray Expands Global Footprint with European Acquisition and North American Growth Strategy

CIBC to Issue 7.000% NVCC AT1 Limited Recourse Capital Notes

Tag: biosimilar

Zentiva and Lupin Sign License and Supply Agreement for TNF alpha inhibitor biosimilar medicine

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us